Repression of YEATS2 induces cellular senescence in hepatocellular carcinoma and inhibits tumor growth

References

• Villanueva A, Longo DL. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi: 10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362. doi: 10.1016/S0140-6736(22)01200-4
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Blasco MA, Partridge L, et al. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243–278.
   PubMed Web of Science ®Google Scholar
• Her J, Bunting SF. How cells ensure correct repair of DNA double-strand breaks. J Biol Chem. 2018;293(27):10502–10511. doi: 10.1074/jbc.TM118.000371
   PubMed Web of Science ®Google Scholar
• Kamal NSM, Safuan S, Shamsuddin S, et al. Aging of the cells: insight into cellular senescence and detection methods. Eur J Cell Biol. 2020;99(6):151108. doi: 10.1016/j.ejcb.2020.151108
   PubMed Web of Science ®Google Scholar
• Selvam SP, Roth BM, Nganga R, et al. Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3. J Biol Chem. 2018;293(25):9784–9800.
   PubMed Web of Science ®Google Scholar
• Ho DH, Seol W, Son L. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein. Cell Cycle. 2019;18(4):467–475. doi: 10.1080/15384101.2019.1577666
   PubMed Web of Science ®Google Scholar
• Zhang L, Pitcher LE, Yousefzadeh MJ, et al. Cellular senescence: a key therapeutic target in aging and diseases. J Clin Invest. 2022;132(15):e158450.
   PubMed Web of Science ®Google Scholar
• Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34(23–24):1565–1576. doi: 10.1101/gad.343129.120
   PubMed Web of Science ®Google Scholar
• Kang TW, Yevsa T, Woller N, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011;479(7374):547–551. doi: 10.1038/nature10599
   PubMed Web of Science ®Google Scholar
• Yang D, Li L, Liu H, et al. Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells. Cell Death Differ. 2013;20(2):235–247. doi: 10.1038/cdd.2012.113
   PubMed Web of Science ®Google Scholar
• Tasdemir N, Banito A, Roe JS, et al. BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Discov. 2016;6(6):612–629.
   PubMed Web of Science ®Google Scholar
• Ruscetti M, Leibold J, Bott MJ, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018;362(6421):1416–1422.
   PubMed Web of Science ®Google Scholar
• Goel S, DeCristo MJ, Watt AC, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017;548(7668):471–475. doi: 10.1038/nature23465
   PubMed Web of Science ®Google Scholar
• Yang J, Liu M, Hong D, et al. The paradoxical role of cellular senescence in cancer. Front Cell Dev Biol. 2021;9:722205. doi: 10.3389/fcell.2021.722205
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi YW, Lee J, et al. Senescent tumor cells lead the collective invasion in thyroid cancer. Nat Commun. 2017;8(1):15208. doi: 10.1038/ncomms15208
   PubMedGoogle Scholar
• Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008;134(4):657–667. doi: 10.1016/j.cell.2008.06.049
   PubMed Web of Science ®Google Scholar
• Sturmlechner I, Zhang C, Sine CC, et al. p21 produces a bioactive secretome that places stressed cells under immunosurveillance. Science. 2021;374(6567):eabb3420. doi: 10.1126/science.abb3420
   PubMed Web of Science ®Google Scholar
• Yeewa R, Chaiya P, Jantrapirom S, et al. Multifaceted roles of YEATS domain-containing proteins and novel links to neurological diseases. Cell Mol Life Sci. 2022;79(3):183. doi: 10.1007/s00018-022-04218-0
   PubMed Web of Science ®Google Scholar
• Wan L, Wen H, Li YY, et al. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Nature. 2017;543(7644):265–269. doi: 10.1038/nature21687
   PubMed Web of Science ®Google Scholar
• Li Y, Wen H, Xi Y, et al. AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation. Cell. 2014;159(3):558–571.
   PubMed Web of Science ®Google Scholar
• Mi W, Guan H, Lyu J, et al. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer. Nat Commun. 2017;8(1):1088. doi: 10.1038/s41467-017-01173-4
   PubMedGoogle Scholar
• Liu N, Konuma T, Sharma R, et al. Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin. Mol Cell. 2023;83(13):2206–2221.e11.
   PubMed Web of Science ®Google Scholar
• Spedale G, Timmers HT, Pijnappel WW. ATAC-king the complexity of SAGA during evolution. Genes Dev. 2012;26(6):527–541. doi: 10.1101/gad.184705.111
   PubMed Web of Science ®Google Scholar
• Zeng Z, Lei S, He Z, et al. YEATS2 is a target of HIF1α and promotes pancreatic cancer cell proliferation and migration. J Cell Physiol. 2021;236(3):2087–2098.
   PubMed Web of Science ®Google Scholar
• Sheng H, Zheng F, Lan T, et al. YEATS2 regulates the activation of TAK1/NF-kappaB pathway and is critical for pancreatic ductal adenocarcinoma cell survival. Cell Biol Toxicol. 2021;39(3):1–16.
   PubMed Web of Science ®Google Scholar
• Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10(9):542–552. doi: 10.1038/nrgastro.2013.87
   PubMed Web of Science ®Google Scholar
• Khare S, Khare T, Ramanathan R, et al. Hepatocellular carcinoma: the role of MicroRNAs. Biomolecules. 2022;12(5):645. doi: 10.3390/biom12050645
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi: 10.1093/bioinformatics/btu170
   PubMed Web of Science ®Google Scholar
• Eichenberger RM. Isolation and analysis of MicroRNAs from extracellular vesicles of the parasitic model nematodes Nippostrongylus brasiliensis and Trichuris muris. Methods Mol Biol. 2021;2369:319–332. doi: 10.1007/978-1-0716-1681-9_17
   PubMedGoogle Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Shen H, Ye F, Xu D, et al. The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma. Cell Death Dis. 2021;13(1):15. doi: 10.1038/s41419-021-04387-z
   PubMed Web of Science ®Google Scholar
• Mustachio LM, Roszik J, Farria A, et al. Targeting the SAGA and ATAC transcriptional coactivator complexes in MYC-driven cancers. Cancer Res. 2020;80(10):1905–1911.
   PubMed Web of Science ®Google Scholar
• Liu X, Hu Y, Li C, et al. Overexpression of YEATS2 remodels the extracellular matrix to promote hepatocellular carcinoma progression via the PI3K/AKT pathway. Cancers (Basel). 2023;15(6):1850. doi: 10.3390/cancers15061850
   PubMed Web of Science ®Google Scholar
• Ewald JA, Desotelle JA, Wilding G, et al. Therapy-induced senescence in cancer. J Natl Cancer Inst. 2010;102(20):1536–1546.
   PubMedGoogle Scholar
• Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol. 2008;76(8):947–957. doi: 10.1016/j.bcp.2008.06.024
   PubMed Web of Science ®Google Scholar
• Demaria M, O’Leary MN, Chang J, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017;7(2):165–176.
   PubMed Web of Science ®Google Scholar
• Coppé JP, Desprez PY, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol Mech Dis. 2010;5(1):99–118.
   PubMed Web of Science ®Google Scholar
• Yan J, Hanif S, Zhang D, et al. Arsenic prodrug-mediated tumor microenvironment modulation platform for synergetic glioblastoma therapy. ACS Appl Mater Interfaces. 2022;14(32):36487–36502. doi: 10.1021/acsami.2c12076
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tchkonia T, Pirtskhalava T, et al. The achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644–658. doi: 10.1111/acel.12344
   PubMed Web of Science ®Google Scholar
• Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007;445(7128):656–660. doi: 10.1038/nature05529
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Zhu Y, van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966–972.
   PubMed Web of Science ®Google Scholar
• Wu L, Tian X, Du H, et al. Bioinformatics analysis of LGR4 in colon adenocarcinoma as potential diagnostic biomarker, therapeutic target and promoting immune cell infiltration. Biomolecules. 2022;12(8):1081. doi: 10.3390/biom12081081
   PubMed Web of Science ®Google Scholar
• Willobee BA, Gaidarski AA, Dosch AR, et al. Combined blockade of MEK and CDK4/6 pathways induces senescence to improve survival in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2021;20(7):1246–1256.
   PubMed Web of Science ®Google Scholar
• Campisi J, Fagagna FDD. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8(9):729–740. doi: 10.1038/nrm2233
   PubMed Web of Science ®Google Scholar
• Muñoz-Espín D, Cañamero M, Maraver A, et al. Programmed cell senescence during mammalian embryonic development. Cell. 2013;155(5):1104–1118. doi: 10.1016/j.cell.2013.10.019
   PubMed Web of Science ®Google Scholar
• Zeng ZM, Du HY, Xiong L, et al. BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest. Life Sci. 2020;244:117342. doi: 10.1016/j.lfs.2020.117342
   PubMed Web of Science ®Google Scholar
• Park KR, Yun JS, Park MH, et al. Loss of parkin reduces lung tumor development by blocking p21 degradation. PLOS ONE. 2019;14(5):e0217037. doi: 10.1371/journal.pone.0217037
   PubMed Web of Science ®Google Scholar
• Yosef R, Pilpel N, Papismadov N, et al. p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. Embo J. 2017;36(15):2280–2295.
   PubMed Web of Science ®Google Scholar
• Chen J, Archer KT. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol Cell Biol. 2005;25(20):9016–9027. doi: 10.1128/MCB.25.20.9016-9027.2005
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Makanae K, Iwasaki S, et al. Post-translational dosage compensation buffers genetic perturbations to stoichiometry of protein complexes. PLOS Genet. 2017;13(1):e1006554. doi: 10.1371/journal.pgen.1006554
   PubMed Web of Science ®Google Scholar
• Choi JY, Shin HJ, Bae IH. miR-93-5p suppresses cellular senescence by directly targeting Bcl-w and p21. Biochem Biophys Res Commun. 2018;505(4):1134–1140. doi: 10.1016/j.bbrc.2018.10.010
   PubMed Web of Science ®Google Scholar